| 12412680 |
Composite superconducting tape, combination and preparation method thereof, and defect bypassing and joint connection method |
— |
2025-09-09 |
|
| 12162844 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2024-12-10 |
$252,679,000 |
| 11871683 |
Charging and field supplement circuit for superconducting magnets based on pulsed current |
Zhiwei Zhang, Zhijian Jin, Yanbo Bi |
2024-01-09 |
|
| 11643400 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2023-05-09 |
$305,124,000 |
| 11229638 |
Therapeutic heterocyclic compounds |
Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein +4 more |
2022-01-25 |
$416,614,000 |
| 11186579 |
Therapeutic heterocyclic compounds |
Mark J. Bartlett, Britton Kenneth Corkey, Kristyna M. Elbel, Rao V. Kalla, Thao Perry |
2021-11-30 |
$447,914,000 |
| 11098027 |
Therapeutic heterocyclic compounds |
Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Elfatih Elzein |
2021-08-24 |
$430,105,000 |
| 11040033 |
Therapeutic heterocyclic compounds |
Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein +4 more |
2021-06-22 |
$444,628,000 |
| 10988451 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2021-04-27 |
$236,030,000 |
| 10703733 |
MCL-1 inhibitors |
Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more |
2020-07-07 |
$851,015,000 |
| 10100058 |
Fused heterocyclic compounds as CaM kinase inhibitors |
Elfatih Elzein, Rao V. Kalla, Dmitry Koltun, Eric Q. Parkhill, Thao Perry +3 more |
2018-10-16 |
$159,225,000 |
| 9695192 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Dmitry Koltun +7 more |
2017-07-04 |
|
| 9682998 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +9 more |
2017-06-20 |
$270,182,000 |
| 9676760 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +7 more |
2017-06-13 |
$212,033,000 |
| 9598435 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +7 more |
2017-03-21 |
$500,566,000 |
| 9403782 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +9 more |
2016-08-02 |
$640,089,000 |
| 9371329 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +5 more |
2016-06-21 |
$611,992,000 |
| 9193694 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Dmitry Koltun +7 more |
2015-11-24 |
$1,013,184,000 |
| 9115096 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +9 more |
2015-08-25 |
$514,598,000 |
| 8962610 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Dmitry Koltun +7 more |
2015-02-24 |
$561,542,000 |
| 8952034 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +5 more |
2015-02-10 |
$366,812,000 |
| 8697863 |
Fused heterocyclic compounds as ion channel modulators |
Elfatih Elzein, Dmitry Koltun, Jeff Zablocki, Chandrasekar Venkataramani |
2014-04-15 |
$344,444,000 |
| 8586732 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Dmitry Koltun +7 more |
2013-11-19 |
$308,376,000 |
| 8389500 |
Fused heterocyclic compounds as ion channel modulators |
Matthew Abelman, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +2 more |
2013-03-05 |
$452,092,000 |
| 8324224 |
A2B adenosine receptor antagonists |
Rao V. Kalla, Thao Perry, Elfatih Elzein, Vaibhav Varkhedkar, Prabha N. Ibrahim +3 more |
2012-12-04 |
$148,543,000 |